Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes
Gene therapy is a promising option for severe forms of genetic diseases. We previously provided evidence for the feasibility of trans-splicing, exon skipping, and gene replacement in a mouse model of hypertrophic cardiomyopathy (HCM) carrying a mutation in MYBPC3, encoding cardiac myosin-binding pro...
Saved in:
Main Authors: | Maksymilian Prondzynski (Author), Elisabeth Krämer (Author), Sandra D. Laufer (Author), Aya Shibamiya (Author), Ole Pless (Author), Frederik Flenner (Author), Oliver J. Müller (Author), Julia Münch (Author), Charles Redwood (Author), Arne Hansen (Author), Monica Patten (Author), Thomas Eschenhagen (Author), Giulia Mearini (Author), Lucie Carrier (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Repair of Mybpc3 mRNA by 5'-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
by: Giulia Mearini, et al.
Published: (2013) -
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity
by: Tim Y. T. Lee, et al.
Published: (2024) -
Unchain My Heart: Integrins at the Basis of iPSC Cardiomyocyte Differentiation
by: Rosaria Santoro, et al.
Published: (2019) -
Hapln1 promotes dedifferentiation and proliferation of iPSC-derived cardiomyocytes by promoting versican-based GDF11 trapping
by: Ding-Jun Hao, et al.
Published: (2024) -
Spontaneous recovery from sunitinib-induced disruption of sarcomere in human iPSC-cardiomyocytes and possible involvement of the Hippo pathway
by: Toshikatsu Matsui, et al.
Published: (2021)